JAGSONPAL PHARMACEUTICALS LIMITED
Regd. Office. T-210 J, Shahpur Jat, New Delhi - 110 049 (INDIA)
Phone: 0091-11-46181100, 46109900
Email:cs@jagsonpal.com;Website: www.jagsonpal.com
CIN No. L74899DL1978PLC009181
August 29, 2022
The Manager | The Manager | |
Listing Agreement | Listing Agreement | |
The National Stock Exchange of India Ltd. | The BSE Limited | |
Exchange Plaza, | Pherojbhoy Jeejeebhoy Tower | |
Bandra-Kurla Complex | Dalal Street, | |
Bandra (E), Mumbai - 400 051. | Mumbai - 400 001. | |
CM Quote: JAGSNPHARM | SCRIP Code: 507789 | |
Subject: Intimation of grant of Employee Stock Options | ||
Dear Sir/Madam,
We wish to inform you that the Nomination and Remuneration Committee today approved the grant of 4,70,000 employee stock options under Jagsonpal Pharmaceuticals Limited Employees Stock Option Plan, 2022 at an exercise price of Rs. 235/- (Rupees Two Hundred Thirty Five Only) per option.
The said options, which are convertible into equivalent number of equity shares of face value of Rs. 5/- each, will vest in 4 equal annual tranches commencing from the first anniversary of the grant.
We request you to kindly take the same on record.
Thanks & Regards,
For JAGSONPAL PHARMACEUTICALS LIMITED
Nandita Singh
Company Secretary & Compliance Officer
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Jagsonpal Pharmaceuticals Ltd. published this content on 29 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 August 2022 01:16:44 UTC.